Clinical Course in Different Molecular Cytogenetic Subgroups
| . | Total No. of Patients . | Patients Alive (all in complete remission) . | Median Survival (all patients; mos) . | . |
|---|---|---|---|---|
| 30 | 17 | 29 (0.5-101) | ||
| 0 and 1 aberration | 15 | 11 | 48 (3-101) | P < .022 |
| ≥2 aberrations | 15 | 6 | 13 (0.5-72) | |
| +11q | 11 | 5 | ||
| p53 deletion | 6 | 3 | ||
| Gains on chromosome 12 | 9 | 2 | ||
| +1q | 4 | 0 | ||
| Amplifications | 4 | 0 |
| . | Total No. of Patients . | Patients Alive (all in complete remission) . | Median Survival (all patients; mos) . | . |
|---|---|---|---|---|
| 30 | 17 | 29 (0.5-101) | ||
| 0 and 1 aberration | 15 | 11 | 48 (3-101) | P < .022 |
| ≥2 aberrations | 15 | 6 | 13 (0.5-72) | |
| +11q | 11 | 5 | ||
| p53 deletion | 6 | 3 | ||
| Gains on chromosome 12 | 9 | 2 | ||
| +1q | 4 | 0 | ||
| Amplifications | 4 | 0 |